You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABT-494

Showing 1 - 25 of 390
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vitiligo Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Vitiligo
  • (no location specified)
Nov 1, 2023

Alopecia Areata Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Alopecia Areata
  • (no location specified)
Aug 22, 2023

Rheumatoid Arthritis Trial (ABT-494, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • ABT-494
  • Placebo
  • (no location specified)
Jul 29, 2021

Hidradenitis Suppurativa Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
May 26, 2023

Crohn's Disease Trial (Placebo, ABT-494)

Completed
  • Crohn's Disease
  • Placebo
  • ABT-494
  • (no location specified)
Jul 30, 2021

Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)

Not yet recruiting
  • Juvenile Idiopathic Arthritis
  • (no location specified)
Nov 7, 2022

Atopic Dermatitis (AD) Trial (Upadacitinib)

No longer available
  • Atopic Dermatitis (AD)
  • (no location specified)
Aug 2, 2021

Atopic Dermatitis Trial in Norway, Puerto Rico, United States (Upadacitinib (ABT-494))

Active, not recruiting
  • Atopic Dermatitis
  • Upadacitinib (ABT-494)
  • Huntington Beach, California
  • +17 more
Jan 25, 2023

Crohn's Disease (CD) Trial in Worldwide (ABT-494)

Active, not recruiting
  • Crohn's Disease (CD)
  • ABT-494
  • La Jolla, California
  • +60 more
Sep 8, 2022

Atopic Dermatitis (AD) Trial (Upadacitinib, Placebo for Upadacitinib)

Withdrawn
  • Atopic Dermatitis (AD)
  • (no location specified)
Apr 7, 2021

Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Curitiba, Parana, Brazil
  • +42 more
Aug 30, 2021

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Hemet, California
  • +62 more
Jul 28, 2021

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +123 more
Jun 15, 2022

Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +152 more
Aug 30, 2022

Non-Segmental Vitiligo Trial in Worldwide (Upadacitinib, Placebo)

Active, not recruiting
  • Non-Segmental Vitiligo
  • Irvine, California
  • +34 more
Jan 31, 2023

Atopic Dermatitis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Tampa, Florida
  • +33 more
Jul 1, 2020

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Mesa, Arizona
  • +166 more
Mar 17, 2022

Atopic Dermatitis Trial in Japan (Upadacitinib, Placebo for upadacitinib, Topical Corticosteroids (TCS))

Completed
  • Atopic Dermatitis
  • Ichinomiya-shi, Aichi, Japan
  • +42 more
Sep 6, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo to Upadacitinib, Methotrexate, Placebo to Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo to Upadacitinib
  • +3 more
  • La Mesa, California
  • +289 more
Dec 1, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +187 more
Feb 14, 2022

Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

Recruiting
  • Takayasu Arteritis (TAK)
  • Salvador, Bahia, Brazil
  • +44 more
Aug 22, 2022

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Ulcerative Colitis (UC) Trial in Worldwide (Upadacitinib (ABT-494), Placebo)

Active, not recruiting
  • Ulcerative Colitis (UC)
  • Upadacitinib (ABT-494)
  • Placebo
  • Mobile, Alabama
  • +490 more
Jan 18, 2022

Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Ulcerative Colitis (UC)
  • Mobile, Alabama
  • +378 more
Feb 17, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
Has Results
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022